NFKB1 and neoplasm: Thirdly, moderate AE directly inhibits the NF-κB signaling pathway, a master regulator of inflammation, thereby reducing the expression of pro-inflammatory cytokines and creating a less favorable tumor immune microenvironment (30, 104).